What should be kept in mind for general anesthesia for pat with liver chirrosis

Reading File
Finding Sources
Finding Sources
Searching PubMed

"liver cirrhosis"[MeSH Terms] AND "anesthesia"[MeSH Terms]

Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
I now have rich, detailed content from multiple authoritative anesthesia textbooks. Let me compile a comprehensive answer.

General Anesthesia in Liver Cirrhosis - Key Considerations

Based on Barash's Clinical Anesthesia (9e), Morgan & Mikhail's Clinical Anesthesiology (7e), Miller's Anesthesia (10e), and Schwartz's Principles of Surgery (11e).

1. Preoperative Risk Assessment

Child-Turcotte-Pugh (CTP) Score

This remains a standard surgical risk tool. Predicted operative mortality correlates with CTP class:
CTP ClassPointsEstimated Surgical Mortality
A5-6~10%
B7-9~30%
C10-1575-80%
Variables scored: serum bilirubin, albumin, INR, degree of encephalopathy, and ascites.

MELD Score

The MELD score (based on INR, bilirubin, creatinine) is an objective, validated predictor. Patients with MELD ≥ 20 face such high mortality that elective surgery should be deferred until after liver transplantation.

VOCAL-Penn Score (2021)

A newer scoring system with a c-statistic of 0.86, outperforming CTP and MELD. Uses bilirubin + 8 other variables including surgery category. Available at www.vocalpennscore.com.
Practical rule: Always classify CTP and calculate MELD before elective surgery. Avoid elective procedures in Child C or MELD ≥ 20 patients.

2. Preoperative Optimization

Before proceeding to the OR, target the following:
  • Infection: Treat any active infection aggressively (spontaneous bacterial peritonitis, UTI, etc.)
  • Coagulopathy: Assess with viscoelastic tests (TEG/ROTEM) rather than relying solely on INR - the INR overestimates bleeding risk because anticoagulant factors (Protein C, antithrombin) are also reduced in proportion
  • Encephalopathy: Optimize lactulose/rifaximin; avoid sedating agents preoperatively
  • Ascites: Minimize but do not over-diurese (risk of hepatorenal syndrome); if large-volume paracentesis is done preoperatively, give albumin replacement (8 g/L of ascites drained)
  • Renal function: Monitor creatinine closely; the renal system is at high risk
  • Hyponatremia: Correct cautiously (avoid rapid correction; osmotic demyelination risk)
  • Nutritional state: Cirrhotic patients frequently have sarcopenia and malnutrition

3. Surgical Approach Matters More Than Anesthetic Technique

A key finding: perioperative risk depends more on the operative site and degree of liver impairment than on the specific anesthetic technique used. Upper abdominal surgery (e.g., cholecystectomy) carries higher risk than pelvic surgery regardless of whether halothane, enflurane, or fentanyl is used.
  • Laparoscopic approach is preferred where feasible - associated with less blood loss, shorter operative time, shorter hospitalization
  • Child A and B: laparoscopic surgery generally safe
  • Child C: consider percutaneous drainage rather than laparoscopic cholecystectomy
  • If severe portal hypertension: consider preoperative TIPS (though TIPS can worsen encephalopathy and raise pulmonary artery pressure)

4. Intraoperative Monitoring

  • Arterial line: Indicated for end-stage liver disease, anticipated blood loss, or hemodynamic instability
  • CVP: Its value for predicting fluid responsiveness is disputed; many centers no longer use it routinely for liver resection
  • Pulmonary artery catheter: For known/suspected pulmonary hypertension or low ejection fraction
  • TEE: Sensitive for preload, contractility, and ejection fraction; safe even in patients with esophageal varices (avoid transgastric views to minimize esophageal trauma)
  • TEG/ROTEM: Best real-time guide for coagulation management - reflects the rebalanced hemostatic system more accurately than INR/PT alone

5. Anesthetic Agent Selection

Volatile Anesthetics

All volatile agents reduce hepatic blood flow to some degree:
AgentEffect on Hepatic Blood Flow
HalothaneGreatest reduction; most cardiovascular depression - avoid
IsofluraneVery little reduction at 1 MAC - preferred
SevofluraneVery little reduction at 1 MAC - preferred
Desflurane~30% reduction at 1 MAC - use cautiously
Isoflurane and sevoflurane are the agents of choice among volatiles.

Intravenous Agents

  • Propofol: No adverse hepatic effect; pharmacokinetics unchanged in cirrhosis; actually increases hepatic blood flow in some studies - safe for induction and TIVA
  • Etomidate: No adverse hepatic effect; pharmacokinetics unchanged
  • Midazolam: Elimination is impaired in liver dysfunction - prolonged sedative effect; reduce dose
  • Ketamine: Can be used but increases hepatic arterial resistance at higher doses

Opioids

  • Morphine, meperidine, alfentanil: Metabolism reduced, duration prolonged - use with caution and reduce doses
  • Fentanyl, sufentanil: In mild hepatic insufficiency, pharmacokinetics are relatively preserved at single doses; with repeated dosing or infusions, accumulation occurs
  • Remifentanil: Ester hydrolysis by tissue esterases (not hepatic) - most predictable duration in cirrhosis; preferred for infusions

Neuromuscular Blocking Agents

  • Succinylcholine / Mivacurium: Prolonged action because pseudocholinesterase (synthesized by liver) is reduced - use with caution
  • Vecuronium, Rocuronium, Pancuronium (aminosteroids): Larger volume of distribution, slower onset, longer duration in cirrhosis - monitor carefully with train-of-four
  • Cisatracurium: Duration unchanged - undergoes Hofmann (spontaneous) degradation, independent of liver function - drug of choice for NMB
  • Sugammadex: Effective for reversing rocuronium in hepatic dysfunction
  • Neostigmine: Reversal unaffected by hepatic dysfunction

6. Neuraxial vs. General Anesthesia

  • High (T5) neuraxial blocks reduce hepatic blood flow and this effect may not be fully reversed by vasopressors - avoid high neuraxial blocks in advanced liver disease
  • Coagulopathy and thrombocytopenia frequently contraindicate neuraxial techniques
  • TAP (transversus abdominis plane) block and quadratus lumborum (QL) block are good regional alternatives for abdominal surgery when neuraxial is contraindicated

7. Coagulation Management

  • Do not reflexively transfuse FFP for an elevated INR - it may overcorrect a rebalanced system and cause thrombosis; the hemostatic system in cirrhosis involves both reduced procoagulant and anticoagulant factors
  • A platelet count > 40,000/μL with elevated vWF (common in cirrhosis) may still yield normal or even hypercoagulable thrombin generation
  • Use TEG/ROTEM to guide transfusion strategy
  • Do not withhold VTE prophylaxis without proper coagulation assessment first
  • Hyperfibrinolysis is common - tranexamic acid may be appropriate intraoperatively

8. Key Intraoperative Concerns

IssueManagement
HypotensionMaintain hepatic perfusion pressure; vasopressors (ephedrine, phenylephrine, norepinephrine); avoid sustained MAP <65 mmHg
Fluid managementBalanced crystalloids preferred; avoid large volumes (worsens ascites); avoid hypotonic fluids
AscitesLarge-volume paracentesis intraoperatively may be needed; replace with albumin
Hepatic encephalopathyAvoid drugs that accumulate (midazolam, morphine); reduce opioid doses
HypoglycemiaMonitor blood glucose; liver's gluconeogenic capacity is impaired
ElectrolytesWatch Na⁺, K⁺, Mg²⁺ (often hyponatremia, hypokalemia in cirrhosis)
HypothermiaActive warming; impaired thermoregulation + high risk of coagulopathy worsening
Pulmonary issuesWatch for hepatopulmonary syndrome (intrapulmonary shunting) and portopulmonary hypertension

9. Postoperative Considerations

  • ICU care for Child B/C patients after major surgery
  • Monitor LFTs postoperatively - "post-hepatectomy liver failure" after resection
  • Avoid NSAIDs (worsen renal function and GI bleeding risk)
  • Avoid hepatotoxic drugs
  • Resume lactulose/rifaximin early to prevent encephalopathy
  • Monitor for spontaneous bacterial peritonitis and renal deterioration (hepatorenal syndrome)
  • Aggressive early mobilization and nutrition

Summary mnemonic - CIRRHOSIS for anesthetic planning:
  • Coagulation - assess with TEG/ROTEM, not just INR
  • Induction agents - propofol/etomidate safe; reduce midazolam
  • Risk scoring - CTP, MELD, VOCAL-Penn before elective surgery
  • Renal function - protect kidneys, avoid nephrotoxins
  • Hepatic blood flow - isoflurane/sevoflurane preferred; avoid halothane
  • Opioids - remifentanil or carefully titrated fentanyl; avoid morphine infusions
  • Succinylcholine/aminosteroids - prolonged; prefer cisatracurium
  • Infection - treat aggressively preoperatively
  • Surveillance - arterial line, TEG, TEE; consider ICU postop
Sources: Barash's Clinical Anesthesia 9e, pp. 3958-3961 | Morgan & Mikhail's Clinical Anesthesiology 7e, pp. 1368-1370 | Miller's Anesthesia 10e, pp. 1532-1533 | Schwartz's Principles of Surgery 11e, pp. 1306-1334

Prevalence and causes of spotting during first trimester

Reading File
Finding Sources
Finding Sources
Searching PubMed

"first trimester bleeding"[MeSH Terms] AND prevalence

Finding Sources
Finding Sources
Searching PubMed

"vaginal bleeding" AND pregnancy AND "first trimester"

Finding Sources
Finding Sources
Reading Article

PMID: 38305047

Finding Sources
Finding Sources
Finding Sources
Searching the Web

prevalence causes spotting first trimester pregnancy clinical review 2023 2024

Reading File
Reading Web Page

https://www.racgp.org.au/afp/2016/may/early-pregnancy-bleedi…

I now have comprehensive information from multiple textbook and clinical sources. Here is the full answer:

Spotting/Bleeding in the First Trimester: Prevalence and Causes


Prevalence

First-trimester bleeding is one of the most common complaints in early pregnancy. Key figures from clinical sources:
  • 15-40% of all pregnant women experience some form of bleeding or spotting in the first 12 weeks
  • Of women who bleed in early pregnancy, approximately 50% will go on to miscarry
  • Among ED patients presenting with pain and/or bleeding in the first trimester, ectopic pregnancy accounts for up to 10% of cases (Rosen's Emergency Medicine)
  • Spotting specifically (lightest form) is the most benign presentation but is still associated with a 15.2% preterm birth rate in cohort data (PMC12664533)

Causes of First-Trimester Spotting/Bleeding

1. Implantation Bleeding

  • Occurs 6-12 days after fertilization when the blastocyst embeds into the endometrium
  • Typically very light, pink or brown, lasts 1-2 days
  • Timing coincides with expected menstruation, leading to confusion
  • Benign, no intervention needed

2. Threatened Miscarriage / Spontaneous Abortion

  • Most common pathological cause
  • Miscarriage complicates 10-20% of clinical pregnancies
  • Presents as vaginal bleeding with closed cervical os; pregnancy may or may not be viable
  • Subtypes:
    • Threatened: Bleeding, closed os, viable fetus on ultrasound
    • Inevitable: Bleeding + dilated os, will not continue
    • Incomplete: Some products of conception (POC) retained
    • Complete: All POC passed
    • Missed (silent): Embryonic death without bleeding or os dilation
  • Risk factors: Advanced maternal age (>35 years), diabetes, thyroid disease, chromosomal anomalies, uterine anomalies
  • ~50% of early miscarriages are due to chromosomal abnormalities

3. Ectopic Pregnancy

  • Most dangerous cause - leading cause of first-trimester maternal death
  • Prevalence: 1-2% of all pregnancies; up to 10% of ED patients with first-trimester pain + bleeding
  • Classic triad: Amenorrhea + lower abdominal pain + vaginal bleeding
  • Sites: Fallopian tube (95%), cornual, cervical, ovarian, abdominal
  • Risk factors:
    • Prior pelvic inflammatory disease (PID)
    • Previous ectopic pregnancy
    • Prior tubal surgery or ligation
    • IUD use
    • Endometriosis
    • Assisted reproduction (IVF)
    • Note: ~50% of women with ectopic pregnancy have NO identifiable risk factors
  • Can rupture and cause life-threatening hemorrhage - requires urgent diagnosis with serum hCG + transvaginal ultrasound

4. Subchorionic Hemorrhage (Subchorionic Hematoma)

  • Collection of blood between the chorion and the uterine wall
  • Detected on ultrasound as a hypoechoic crescent-shaped area
  • One of the most common sonographic findings in first-trimester bleeding
  • Small hematomas often resolve spontaneously; large ones carry higher miscarriage risk
  • Management: Pelvic rest, close ultrasound follow-up

5. Gestational Trophoblastic Disease (Molar Pregnancy)

  • Abnormal proliferation of trophoblastic tissue
  • Types: Complete hydatidiform mole (no fetal tissue), partial mole (abnormal fetal tissue)
  • Classic features: Bleeding + abnormally elevated serum hCG + "snowstorm" appearance on ultrasound + uterus large for dates
  • Rare but must always be considered; malignant transformation (choriocarcinoma) possible

6. Cervical Causes

Increased vascularity of the cervix in pregnancy predisposes to bleeding from:
  • Cervical ectropion (erosion): Columnar epithelium exposed on ectocervix; bleeds easily, especially post-coital
  • Cervical polyps: Pedunculated growths; benign but can bleed
  • Cervicitis/STI: Chlamydia, gonorrhea, trichomonas; associated with discharge + bleeding
  • Cervical malignancy: Rare but must be excluded - check Pap smear history
  • Post-coital bleeding (contact bleeding) is common in pregnancy due to increased cervical vascularity

7. Corpus Luteum Cyst Rupture

  • The corpus luteum produces progesterone to maintain early pregnancy until the placenta takes over (~10-12 weeks)
  • Rupture causes acute pelvic pain + intraperitoneal bleeding
  • May mimic ectopic pregnancy on clinical presentation
  • Differentiated by ultrasound (intrauterine pregnancy present + free fluid)

8. Vaginal Causes

  • Trauma (most commonly post-coital)
  • Vaginal varicosities
  • Vaginal infections/vaginitis

9. Uterine Infection

  • Endometritis in early pregnancy
  • Associated with fever, uterine tenderness, purulent discharge
  • Rare in the first trimester but must be considered

10. Heterotopic Pregnancy

  • Simultaneous intrauterine + ectopic pregnancy
  • Rare in natural conception (1 in 30,000), but incidence increases significantly with IVF/ART
  • Dangerous because the intrauterine pregnancy can mask the ectopic

Summary Table

CauseFrequencyKey Feature
Implantation bleedingCommonDays 6-12, very light, benign
Threatened miscarriage10-20% pregnanciesViable fetus, closed os
Spontaneous abortion10-20% pregnanciesUp to 50% of bleeding cases
Subchorionic hematomaCommon on USSHypoechoic crescent on scan
Cervical ectropionCommonPost-coital, on speculum exam
Cervical polyp/cervicitisLess commonContact bleeding
Ectopic pregnancy1-2% pregnanciesPain + bleeding, life-threatening
Corpus luteum cyst ruptureUncommonAcute pain, free fluid
Molar pregnancyRareVery high hCG, "snowstorm" USS
Heterotopic pregnancyVery rareIVF patients especially
Cervical malignancyVery rareCheck Pap history

Clinical Significance of Spotting (vs. Heavier Bleeding)

A 2023-2024 cohort study (PMC12664533) stratified outcomes by bleeding severity:
OutcomeSpottingLight BleedingHeavy Bleeding
Preterm birth15.2%23.7%34.6%
Hypertension8.7%13.2%19.2%
Low birth weight17.4%26.3%42.3%
NICU admission10.9%21.1%38.5%
A 2024 systematic review (PMID 38305047) confirmed that first-trimester vaginal bleeding increases the relative risk of preterm birth, low birth weight, premature rupture of membranes, placental abruption, and placenta previa later in pregnancy.

Key Workup When a Patient Presents with First-Trimester Bleeding

  1. Serum hCG (quantitative) - Is it rising appropriately? (Doubles every 48 hrs in normal IUP)
  2. Transvaginal ultrasound - Confirm intrauterine location, viability, and gestational age
  3. Blood group + Rh typing - Rh-negative women need anti-D immunoglobulin if bleeding occurs
  4. Speculum examination - Identify cervical/vaginal source; cervical os status
  5. STI screening if cervicitis suspected
Sources: Rosen's Emergency Medicine, p. 333 | RACGP/Australian Family Physician (Breeze, 2016) | ACOG | PMC12664533 (Cohort, 2023-24) | PMID 38305047 (Systematic Review, 2024)

Types of miscarriages and how to diagnose?

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Loading Image
I now have all the information needed. Here is a comprehensive, well-structured answer:

Types of Miscarriage (Spontaneous Abortion) and Diagnosis

Spontaneous abortion = unintentional loss of pregnancy before 20 weeks' gestation (or fetus <500 g, per WHO). About 8-20% of known pregnancies end this way; ~80% occur in the first trimester. About 75% occur before 8 weeks.

Overview of Types

TypeCervical OsTissue PassedFetal ViabilityKey Feature
ThreatenedClosedNoneViableBleeding only - may not miscarry
InevitableOpen / dilatingNone yetNot viableWill definitely miscarry
IncompleteOpenPartialNot viableSome POC retained
CompleteClosed (after)AllNot viableAll POC passed
Missed (Silent)ClosedNoneDeadNo symptoms; found on scan
SepticAnyAnyNot viableInfection superimposed
Recurrent---3+ consecutive losses

1. Threatened Abortion

Definition: Vaginal bleeding before 20 weeks with a closed cervical os and a viable intrauterine pregnancy confirmed on ultrasound.
  • Occurs in at least 20-25% of all pregnancies
  • Bleeding is usually light; may have mild lower abdominal cramping
  • About 12% of women with first-trimester bleeding will ultimately miscarry (similar to background rate)
  • Women with threatened abortion who continue their pregnancy have nearly 3x risk of preterm birth at 28-31 weeks, and a 50% higher risk between 32-36 weeks
  • There is no effective treatment - bed rest and progesterone have not been proven to prevent miscarriage
How to Diagnose:
  • Clinical: Vaginal bleeding + closed os + non-tender abdomen
  • Transvaginal ultrasound (TVU): Intrauterine gestational sac with fetal cardiac activity confirmed
  • Serum hCG: Should be rising appropriately (doubles every 48 hrs in normal IUP)
  • Rule out: cervical polyp, ectropion, ectopic pregnancy, molar pregnancy

2. Inevitable Abortion

Definition: Cervical os is open and effaced before 20 weeks, but no tissue has yet passed. The pregnancy cannot be saved.
  • Most patients have crampy lower abdominal pain
  • May have cervical motion tenderness or adnexal tenderness
  • Profuse bleeding may occur
How to Diagnose:
  • Clinical: Open/dilating cervical os + bleeding (± ruptured membranes)
  • Ultrasound: Gestational sac may be seen at os or in lower uterine segment; no cardiac activity
  • hCG: Falling or plateaued

3. Incomplete Abortion

Definition: Partial expulsion of products of conception (POC) - some tissue remains in the uterus.
  • More likely between 6-14 weeks (when placenta is firmly attached)
  • Pain resembles labor - severe crampy lower abdominal pain
  • Heavy vaginal bleeding
  • Cervix is dilated, tissue may be visible at or through the os
How to Diagnose:
  • Clinical: Dilated os + tissue at os + ongoing heavy bleeding
  • Ultrasound: Heterogeneous material within the uterine cavity (retained POC); endometrial thickness typically >15 mm with irregular contents
  • hCG: Elevated but not rising normally
Management: Uterine evacuation is required - surgical (suction curettage/D&C) or medical (misoprostol 600 mcg oral or 400 mcg sublingual, efficacy >90%)

4. Complete Abortion

Definition: All gestational products have been expelled before 20 weeks.
  • Bleeding and cramping typically subside after passage of all tissue
  • Cervical os closes after expulsion
How to Diagnose:
  • Clinical: History of tissue passage + cessation of bleeding and pain
  • Ultrasound: Empty uterine cavity (thin endometrial stripe, no retained products)
  • Serial hCG: Falling toward zero
  • Must confirm by examining passed products of conception
Important: A complete abortion cannot be diagnosed clinically alone - ultrasound confirmation of an empty uterus is essential to rule out retained POC and ectopic pregnancy.

5. Missed Abortion (Silent / Delayed Miscarriage)

Definition: Embryonic or fetal death at <20 weeks without expulsion of products for at least 4 weeks after death; closed cervix, minimal or no bleeding or pain.
Often discovered incidentally on routine ultrasound.

Subtypes:

a) Anembryonic Gestation (Blighted Ovum)
  • Embryo failed to develop; only the gestational sac forms
  • Ultrasound diagnosis: Mean sac diameter (MSD) >25 mm with no embryonic pole on transvaginal ultrasound
  • hCG may be lower than expected for gestational age
b) Embryonic Demise (Early Fetal Demise)
  • Embryo present but no cardiac activity
  • Ultrasound diagnosis: Crown-rump length (CRL) >7 mm with no cardiac activity on TVU
How to Diagnose:
  • Primarily by transvaginal ultrasound (most reliable)
  • Serial ultrasounds may be needed if findings are borderline (to eliminate false diagnosis of non-viability)
  • Serial hCG: Not rising appropriately or falling
  • Cervix is closed on examination
Diagnosis should use conservative criteria to avoid terminating a potentially viable pregnancy. A single scan should not conclude non-viability unless criteria are clearly met.

6. Septic Abortion

Definition: Infection of the uterus and/or products of conception occurring at any stage of abortion. Most commonly complicates incomplete abortions.
  • Previously common with unsafe induced abortions; now also seen with incomplete spontaneous abortions
  • Can rapidly progress to septicemia, septic shock, and death
How to Diagnose:
  • Clinical triad: Fever + uterine tenderness + foul-smelling/purulent vaginal discharge
  • Additional signs: Leukocytosis, tachycardia, lower abdominal tenderness, cervical motion tenderness
  • Labs: CBC (leukocytosis), blood cultures, CRP, urine culture
  • Ultrasound: May show retained POC ± gas in the uterus (in severe infection)
  • Broad-spectrum antibiotics + uterine evacuation (D&C) are both required urgently - evacuation is NOT contraindicated

7. Recurrent Pregnancy Loss (RPL / Habitual Abortion)

Definition: 3 or more consecutive first-trimester pregnancy losses (some guidelines now use 2 consecutive losses).
  • Affects ~1% of couples
  • After 1 loss: risk in next pregnancy 13-20%; after 3 losses: 33-43%
  • Warrants systematic evaluation for underlying cause
Causes to Investigate:
CategoryCause
GeneticParental chromosomal anomalies (balanced translocations); embryonic aneuploidy
AnatomicUterine septum, bicornuate uterus, submucous fibroids, intrauterine adhesions (Asherman's), cervical incompetence
EndocrineUncontrolled diabetes, thyroid disease, luteal phase defect, PCOS
ThrombophilicAntiphospholipid syndrome (most treatable cause)
ImmunologicalAlloimmune rejection (less well-established)
Unexplained~50% of cases
Workup for RPL:
  • Parental karyotype
  • Uterine anatomy: Hysterosalpingography (HSG), saline-infusion sonography, or hysteroscopy
  • Antiphospholipid antibodies (anticardiolipin, lupus anticoagulant, anti-β2 glycoprotein I)
  • TSH, fasting glucose/HbA1c
  • Fetal/POC karyotype (from passed tissue)

Diagnostic Workup Summary for Any Suspected Miscarriage

History → LMP, bleeding amount, pain, prior losses, risk factors
   ↓
Vitals + Speculum exam → os status, active bleeding, tissue at os
   ↓
Quantitative serum β-hCG
   ↓
Transvaginal Ultrasound (TVU)
   ↓
Blood group + Rh factor → give RhoGAM if Rh-negative
   ↓
CBC if heavy bleeding suspected
   ↓
Serial hCG + repeat TVU in 48-72 hrs if diagnosis uncertain

Key TVU Diagnostic Criteria (Summary)

FindingInterpretation
Gestational sac + fetal pole + cardiac activityViable IUP (threatened if bleeding)
MSD >25 mm, no embryoAnembryonic gestation (missed abortion)
CRL >7 mm, no cardiac activityEmbryonic demise (missed abortion)
Heterogeneous material in cavityIncomplete abortion / retained POC
Empty uterine cavityComplete abortion (or very early IUP or ectopic)
Empty uterus + hCG ≥1500 mIU/mLSuspicious for ectopic pregnancy
hCG discriminatory zone: When serum hCG ≥1500 mIU/mL, an intrauterine gestational sac should normally be visible on TVU. Absence of an IUP at this level raises strong concern for ectopic pregnancy.

Sources: Berek & Novak's Gynecology, pp. 1749-1753 | Textbook of Family Medicine 9e, p. 493 | Tintinalli's Emergency Medicine, p. 968 | Rosen's Emergency Medicine, p. 333
This is a shared conversation. Sign in to Orris to start your own chat.